Abbott Laboratories (ABT)
Abbott Laboratories Accounts Receivable: 7.660B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ABT Accounts Receivable Rankings
| Overall | 98th percentile | 72 of 3768 |
| Sector | 98th percentile | 8 of 442 in Healthcare |
| Industry | 58th percentile | 7 of 17 in Drug Manufacturers - Major |
ABT Accounts Receivable Range, Past 5 Years
| Minimum | 3.395B | Jun 2007 |
| Maximum | 7.684B | Dec 2011 |
| Average | 5.939B |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these ABT related companies
ABT News
EBR: Watchlist/worksheet/4 Trading Ideas: $FIRE $WG $ABT $ANGI http://stks.co/3vnQ
about 5 days ago by TheEquitiesRoom
about 5 days ago by TheEquitiesRoom
I believe $ABT will go up in the next couple of day to a second top of a double top and then go south
about 6 days ago by john_abot
about 6 days ago by john_abot
Price target on $ABT is 64 but I could easily see a 3% pullback to the 50 day if market volatility keeps up. Either way long-term entry.
about 9 days ago by AlphaoverBetaTrading
about 9 days ago by AlphaoverBetaTrading
$OSUR fromwith first non-prescription HIV test buyout becomes very real $JNJ $ABT $ROG very nice price here
about 11 days ago by leahcim474
about 11 days ago by leahcim474
Listen to $ABT Abbott at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3if1
about 19 days ago by earningscast
about 19 days ago by earningscast
got mixed up, I meant $ABT in trouble because they pleaded guilty to rebranding a drug http://stks.co/3iDN
about 19 days ago by epime7heus
about 19 days ago by epime7heus
@jimcramer 's $ABT in trouble. His $COG and $CELG also still terrible recomendations. Worst in my port.
about 20 days ago by epime7heus
about 20 days ago by epime7heus
$CHK Scary day in the stock market when this is my best performing stock in my portfolio today. $CHK and $ABT are my only green.
about 24 days ago by baumusc
about 24 days ago by baumusc
$ABT http://stks.co/3ZBj closed Friday on shrinking candles & near doji at RSI 70+, will see if rests or drives higher
about 28 days ago by harmongreg
about 28 days ago by harmongreg
$VVUS halt is becuase FDA pre released and co wanted AH... might not open until monday. at 28-30 plus... $PFE $ABT wants this drug and co.
about 30 days ago by selectstock
about 30 days ago by selectstock
$ABT evening star on te daily or perhaps just a pause. No positions.
about 30 days ago by indiantraveler
about 30 days ago by indiantraveler
RT @indiantraveler $ABT //BTO May 62.5 for 9c //taking 1/3 off at .28 //another 1/3 taken off./closed final 1/3. +2415
about 31 days ago by indiantraveler
about 31 days ago by indiantraveler
$ABT //BTO May 62.5 for 9c //taking 1/3 off at .28 //another 1/3 taken off.
about 32 days ago by indiantraveler
about 32 days ago by indiantraveler
RT @harmongreg $ABT //BTO May 62.5 for 9c //taking 1/3 off at .28
about 32 days ago by indiantraveler
about 32 days ago by indiantraveler
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABT | 62.25 | -0.17 | -0.27% | 97.88B |
| ABR | 5.85 | +0.04 | +0.69% | 141.22M |
| ABMD | 20.80 | -1.12 | -5.11% | 810.99M |
| ABM | 21.73 | +0.05 | +0.23% | 1.159B |
| ABIO | 0.69 | +0.14 | +25.45% | 7.259M |
| ABH | 11.83 | +0.00 | +0.00% | 1.149B |
| ABFS | 12.99 | +0.15 | +1.17% | 330.60M |
| ABD | 9.40 | -0.08 | -0.84% | 523.11M |
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ACH | 10.07 | -0.25 | -2.42% | 1.589B |